Loading...
Lisinopril
India Pharmaceutical Trade Intelligence
Who Supplies Lisinopril to India from UNITED STATES
India's lisinopril imports from UNITED STATES total $103.5K across 50 shipments from 13 foreign suppliers. PHARMACEUTICAL BUYERS, INC leads with $40.6K in import value; the top 5 suppliers together control 92.8% of this origin. Leading Indian buyers include WATSON PHARMA PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for lisinopril — a diversified sourcing base with multiple active suppliers from UNITED STATES.
Top foreign suppliers (UNITED STATES) — Ranked by import value
PHARMACEUTICAL BUYERS, INC is the leading Lisinopril supplier from UNITED STATES to India, with import value of $40.6K across 8 shipments. The top 5 suppliers — PHARMACEUTICAL BUYERS, INC, PHARMACEUTICAL BUYERS, INC., ADIRAMEDICA LLC, M/S RAFF & HALL PHARMACY, SSS PHARMACY INC — collectively account for 92.8% of total import value from this origin.
Top foreign suppliers (UNITED STATES)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | PHARMACEUTICAL BUYERS, INC | $40.6K | 8 | 39.2% |
| 2 | PHARMACEUTICAL BUYERS, INC. | $37.2K | 6 | 36.0% |
| 3 | ADIRAMEDICA LLC | $9.1K | 2 | 8.8% |
| 4 | M/S RAFF & HALL PHARMACY | $5.4K | 6 | 5.2% |
| 5 | SSS PHARMACY INC | $3.7K | 3 | 3.6% |
| 6 | M/S NEWLIFE MEDICALS (USA). INC. | $2.8K | 2 | 2.7% |
| 7 | NEWLIFE MEDICALS (USA). INC. | $2.5K | 2 | 2.4% |
| 8 | ACTAVIS LABORATORIES FL, INC | $756 | 2 | 0.7% |
| 9 | EVARIC PHARMACEUTICALS INC | $642 | 14 | 0.6% |
| 10 | ILAPO-INTERNATIONALE LUDWIGS- | $375 | 1 | 0.4% |
| 11 | NewLife Medicals (USA). Inc. | $246 | 1 | 0.2% |
| 12 | Actavis Laboratories UT Inc | $138 | 1 | 0.1% |
| 13 | EVARIC PHARMACEUTICALS INC. | $30 | 2 | 0.0% |
Showing top 13 of 13 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from UNITED STATES)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | WATSON PHARMA PRIVATE LIMITED | $58.8K | 14 | 56.8% |
| 2 | WATSON PHARMA PVT.LTD. | $20.3K | 4 | 19.6% |
| 3 | AXXELENT PHARMA SCIENCE PRIVATE LIMITED | $9.1K | 2 | 8.8% |
| 4 | GRAVITI PHARMACEUTICALS PRIVATE LIMITED | $8.2K | 8 | 7.9% |
| 5 | AUROBINDO PHARMA LTD | $6.2K | 5 | 6.0% |
| 6 | HETERO LABS LIMITED | $474 | 11 | 0.5% |
| 7 | AZURITY PHARMACEUTICALS INDIA LLP | $246 | 1 | 0.2% |
| 8 | HETERO LABS LIMITED | $168 | 3 | 0.2% |
| 9 | CLIANS LABS PRIVATE LIMITED | $30 | 2 | 0.0% |
Import Statistics
- Import Value
- $103.5K
- Shipments
- 50
- Foreign Suppliers
- 13
- Indian Buyers
- 9
- Avg. Shipment
- $2.1K
Other Lisinopril Import Origins
Related Analysis
Frequently Asked Questions — Lisinopril Imports from UNITED STATES
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Lisinopril suppliers from UNITED STATES to India?
The top Lisinopril suppliers from UNITED STATES to India include PHARMACEUTICAL BUYERS, INC, PHARMACEUTICAL BUYERS, INC., ADIRAMEDICA LLC. The leading supplier is PHARMACEUTICAL BUYERS, INC with import value of $40.6K USD across 8 shipments. India imported Lisinopril worth $103.5K USD from UNITED STATES in total across 50 shipments.
QHow much Lisinopril does India import from UNITED STATES?
India imported Lisinopril worth $103.5K USD from UNITED STATES across 50 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Lisinopril from UNITED STATES?
The main Indian buyers of Lisinopril sourced from UNITED STATES include WATSON PHARMA PRIVATE LIMITED, WATSON PHARMA PVT.LTD., AXXELENT PHARMA SCIENCE PRIVATE LIMITED. The largest buyer is WATSON PHARMA PRIVATE LIMITED with $58.8K in imports across 14 shipments.
QWhat is the total value of Lisinopril imports from UNITED STATES to India?
The total value of Lisinopril imports from UNITED STATES to India is $103.5K USD, across 50 shipments and 13 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: UNITED STATES to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Lisinopril.
- 2.Supplier/Buyer Matching: 13 foreign suppliers from UNITED STATES and 9 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $103.5K aggregated from 50 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
50 Verified Shipments
13 suppliers, 9 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists